Even though CD4+ T lymphocytes might have a significant influence on the peripheral immune processes that lead to multiple sclerosis, it has been known for a long time that CD8+ T lymphocytes are more prevalent than CD4+ T lymphocytes in the brain lesions of MS patients. This evidence concerns the gene CD8A and myeloid sarcoma.